<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17814" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Argyria</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jerger</surname>
            <given-names>Stephanie E.</given-names>
          </name>
          <aff>Garden City Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Parekh</surname>
            <given-names>Utsav</given-names>
          </name>
          <aff>Pramukhswami Medical College, Karamsad, Gujarat (India)</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephanie Jerger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Utsav Parekh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17814.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Argyria is a dermatologic condition that is acquired by exposure to or ingestion of silver, and it presents with the insidious onset of gray or blue mucocutaneous discoloration. While it is considered a benign condition, the diagnosis is difficult, and it is often mistaken for other more common dermatologic conditions. This activity describes the evaluation and explains the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the sources of exposure to silver in the etiology of argyria.</p></list-item><list-item><p>Describe the physical exam findings in patients with argyria.</p></list-item><list-item><p>Outline the histopathologic findings of a skin biopsy of an individual diagnosed with argyria.</p></list-item><list-item><p>Summarize the importance of interprofessional team strategies for improving care coordination and communication in patients with argyria to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17814&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17814">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17814.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Argyria is an acquired condition caused by the exposure to or ingestion of silver, and it presents with the insidious onset of gray or blue mucocutaneous discoloration. The word argyria is derived from the ancient Greek word for silver, argyros. Argyria can cause localized or generalized skin pigmentation, depending on the form of silver exposure. Silver, in its elemental form, is a precious, white transition metal. It exhibits the highest electrical conductivity, thermal conductivity, and reflectivity of all the metals, giving it a wide array of uses.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref>&#x000a0;</p>
        <p>Silver has a diverse role in society, from jewelry to filtration devices. Silver coins can be found in various economies as a financial currency. Interestingly, the phrase "born with a silver spoon in his mouth" refers to health instead of wealth. Silver spoons, as well as silver pacifiers, were once believed to prevent childhood illnesses.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref>&#x000a0;The medicinal and health benefits of silver still resonate in the current society because of the oligodynamic effect. The antimicrobial property of silver is related to the released Ag ions and their ability to interact and irreversibly damage bacterial membranes.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref><xref ref-type="bibr" rid="article-17814.r2">[2]</xref></p>
      </sec>
      <sec id="article-17814.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common causes of argyria are secondary to exposures in the workplace or medicinal use. Jewelers, silver miners, silversmiths, and photograph developers are frequently exposed to compounds containing silver.<xref ref-type="bibr" rid="article-17814.r3">[3]</xref>&#x000a0;Occupational argyria, often transdermal, transmucosal, or inhaled, tends to be more localized to a specific area of the body; for instance, the fingers of a jewelry polisher. Of note, there have been reported cases of ocular argyrosis in silversmiths due to the deposition of silver in the cornea.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref></p>
        <p>Medicinal exposure has become much less common in the modern-day era since the antimicrobial&#x000a0;properties of silver are unavailing&#x000a0;when compared to&#x000a0;today's antibiotics.&#x000a0;As a result, there are minimal FDA-approved medicinal uses for products containing silver in the United States.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref>&#x000a0;In modern medicine, silver is utilized in medical-grade forms, including silver sulfadiazine and silver nitrate.<xref ref-type="bibr" rid="article-17814.r2">[2]</xref>&#x000a0;Medical uses that that are approved by the FDA are&#x000a0;listed below<xref ref-type="bibr" rid="article-17814.r5">[5]</xref><xref ref-type="bibr" rid="article-17814.r6">[6]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;Ophthalmic silver nitrate for gonorrheal ophthalmia neonatorum</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Cutaneous silver nitrate for mucosal cautery</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Cutaneous silver sulfadiazine for wounds secondary to second and third-degree burns</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Mucocutaneous silver acetate for smoking cessation because of its foul, metallic taste when combined with smoke</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Silver impregnated catheters and endotracheal tubes as an antimicrobial adjunct.</p>
          </list-item>
        </list>
        <p>Despite the dwindling&#x000a0;medicinal uses, there is still a market for colloidal silver as a&#x000a0;cure-all in alternative and homeopathic medicine.<xref ref-type="bibr" rid="article-17814.r5">[5]</xref>&#x000a0;It is advertised as an immune&#x000a0;system promoter,&#x000a0;and it is readily available&#x000a0;online and&#x000a0;over-the-counter in pharmacies and grocery stores. Also, the hygiene capacities of silver have resulted in the addition of silver to toothpaste, contact lenses, bandaids, hair dye, and breast pump assemblies.<xref ref-type="bibr" rid="article-17814.r2">[2]</xref></p>
      </sec>
      <sec id="article-17814.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Argyria is much less common in the 21st century because of the decline in heavy exposure to silver and its use in medicine; however, it does still exist. Generalized argyria cases in modern society are typically seen in individuals who consume colloidal silver as a form of alternative medicine.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref>&#x000a0;Argyria affects individuals of all races, genders, and age groups without any specific predilection.</p>
      </sec>
      <sec id="article-17814.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The body tends to store a small amount of natural silver, so the cumulative content of silver increases with age in the body.&#x000a0;The accumulated composition is comprised of the binding protein and is present in tissues.&#x000a0;With an increased amount of silver,&#x000a0;the photoactivation and metal reduction produce a bluish-gray discoloration of the skin in light-exposure areas.<xref ref-type="bibr" rid="article-17814.r7">[7]</xref></p>
        <p>There are three subtypes of argyria<xref ref-type="bibr" rid="article-17814.r8">[8]</xref>:</p>
        <p>1. Generalized argyria: This is due to&#x000a0;systemic exposure to silver followed by its uptake by the dermis,&#x000a0;leading to a gray/blue saltish or metallic diffuse hue to the skin. This color difference&#x000a0;becomes evident predominantly in sun-exposed areas.</p>
        <p>Azure lunula is a subtype in which there will be a bluish discoloration of the&#x000a0;lunula of the fingernails.</p>
        <p>2.&#x000a0;Localized argyria: This is due to&#x000a0;local silver deposition through&#x000a0;skin incisions or percutaneous absorption via sweat gland pores. The resultant macular spots or clusters of spots tend to&#x000a0;be darker, sometimes almost black.</p>
        <p>Amalgam tattoo is the most common subtype of localized argyria&#x000a0;and is due to&#x000a0;the impregnation of silver-contained dental amalgam into oral mucosa that may occur during restorative dentistry procedures. It is characterized by a&#x000a0;flat, dark-blue mucosal lesion near a restored tooth.</p>
        <p>3. Argyrosis:&#x000a0;This is due to the deposition of silver in the eye. The lesions have a predilection for the corneal Descemet membrane and appear small, darker lesions with greenish and brownish tones.</p>
      </sec>
      <sec id="article-17814.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histological examination of a skin biopsy in patients suspected to have argyria will reveal numerous, tiny, brown, or black granules, which are deposited in a linear distribution along the basement membrane of eccrine glands.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref><xref ref-type="bibr" rid="article-17814.r7">[7]</xref>&#x000a0;There are also granule deposits&#x000a0;in the elastic and collagen fibers within the papillary dermis. Deposits of silver can be confirmed using hematoxylin and eosin staining under microscopy.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref>&#x000a0;</p>
        <p>The epidermis is spared, which is a characteristic that may be used&#x000a0;to help distinguish&#x000a0;argyria from other pigmentation disorders.<xref ref-type="bibr" rid="article-17814.r9">[9]</xref><xref ref-type="bibr" rid="article-17814.r10">[10]</xref><xref ref-type="bibr" rid="article-17814.r11">[11]</xref>&#x000a0;Histologically, argyria can be mistaken for melanoma. Despite that,&#x000a0;it is not a precancerous nor a cancerous condition.<xref ref-type="bibr" rid="article-17814.r12">[12]</xref></p>
      </sec>
      <sec id="article-17814.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history should include some type of silver exposure. Physical examination of the patient reveals a blue or gray discoloration of the skin, which may be generalized or evident only in a localized area of the body.<xref ref-type="bibr" rid="article-17814.r13">[13]</xref>&#x000a0;An individual's sclera, mucosa, and nails can also be affected. Sun-exposed areas are typically darker, and this is thought to be a direct result of sunlight acting as a catalyst to the reduction of elemental silver, thereby resulting in a darker pigmented discoloration.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref></p>
      </sec>
      <sec id="article-17814.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Argyria is considered a diagnosis of exclusion, and most cases are diagnosed after a thorough history and physical exam. The gold standard for diagnosis is a skin biopsy of the affected region of the body.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref>&#x000a0;As discussed in the histopathology section, a biopsy of an affected area of skin will show brown or black granules deposited along the basement membrane, surrounding eccrine glands and hair follicles.<xref ref-type="bibr" rid="article-17814.r1">[1]</xref><xref ref-type="bibr" rid="article-17814.r7">[7]</xref>&#x000a0;Energy-Dispersive X-ray Spectroscopy (EDXS) is the non-invasive gold standard technique. Dermatoscopy for localized argyrosis and slit-lamp biomicroscopy for argyrosis are other methods used for the diagnosis.<xref ref-type="bibr" rid="article-17814.r8">[8]</xref></p>
      </sec>
      <sec id="article-17814.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Argyria is considered a permanent, irreversible skin condition.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref>&#x000a0;Many potential treatments have been attempted without success. Among these, chelation has been attempted but was not effective.<xref ref-type="bibr" rid="article-17814.r14">[14]</xref>&#x000a0;Dermabrasion and hydroquinone have been trialed without notable results.<xref ref-type="bibr" rid="article-17814.r7">[7]</xref>&#x000a0;</p>
        <p>Recently, a few studies have documented the temporary improvement of cosmesis after laser treatments. One study highlights the use of Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy and its utility in the removal of very&#x000a0;dark pigmented tattoos.&#x000a0;It was thought that this&#x000a0;could be utilized in an&#x000a0;attempt to reduce the gray and blue pigmentation in patients with argyria. However, the study found that the fluence of this particular laser therapy is too high for argyria, and it induced pinpoint bleeding and marked pain.</p>
        <p>However, when a low-fluence 1064-nm Q-switched Nd:YAG laser using a top-hat mode was utilized, there was documentation of successful resolution of discoloration following seven treatments.<xref ref-type="bibr" rid="article-17814.r15">[15]</xref>&#x000a0;Unfortunately, this resolution may only be temporary, as&#x000a0;there have been documented cases of argyria recurring approximately 1 year after Q-switched Nd:YAG laser therapy was performed.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref><xref ref-type="bibr" rid="article-17814.r15">[15]</xref><xref ref-type="bibr" rid="article-17814.r16">[16]</xref><xref ref-type="bibr" rid="article-17814.r17">[17]</xref></p>
      </sec>
      <sec id="article-17814.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cyanosis</p>
          </list-item>
          <list-item>
            <p>Hemochromatosis</p>
          </list-item>
          <list-item>
            <p>Methemoglobinemia</p>
          </list-item>
          <list-item>
            <p>Methylene blue poisoning</p>
          </list-item>
          <list-item>
            <p>Melanoma</p>
          </list-item>
          <list-item>
            <p>Ochronosis</p>
          </list-item>
          <list-item>
            <p>Chrysiasis</p>
          </list-item>
          <list-item>
            <p>Amiodarone, minocycline, or phenothiazines&#x000a0;use</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17814.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Argyria is exacerbated by continued silver ingestion or exposure, and this is due to&#x000a0;an accumulative effect. It does not improve after discontinuing exposure.&#x000a0;Ultimately, the prognosis is permanent&#x000a0;skin discoloration of the areas affected.<xref ref-type="bibr" rid="article-17814.r12">[12]</xref>&#x000a0;Although not a life-threatening condition, it results in an unfavorable cosmetic outcome.<xref ref-type="bibr" rid="article-17814.r4">[4]</xref></p>
      </sec>
      <sec id="article-17814.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Argyria is the dermatological manifestation of chronic silver exposure toxicity. However, if a large&#x000a0;quantity of silver-containing compounds is&#x000a0;acutely ingested, silver toxicity can occur and may be fatal. The dose needed to be fatal is 50 mg or more of intravenous colloidal silver. This would lead to pulmonary edema, hemorrhage, and necrosis of bone marrow, liver, and kidneys.<xref ref-type="bibr" rid="article-17814.r18">[18]</xref></p>
      </sec>
      <sec id="article-17814.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although argyria does not have life-threatening complications, cosmetic concerns may induce psychological distress to the patients. Psychological counseling and education about the available treatment modalities would be beneficial. Self-administration of the colloidal silver by the patient from various internet sources&#x000a0;should be discouraged.</p>
      </sec>
      <sec id="article-17814.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Argyria is a rare dermatologic skin condition that poses a diagnostic dilemma. Patients often present with the insidious onset of generalized or localized skin discoloration without associated symptoms. Due to the infrequency of this condition, clinicians may not be versed in detecting the disease, potentially leading to a lack of a diagnosis or a misdiagnosis.</p>
        <p>While it is imperative for the clinician to obtain a detailed history, including all medications and supplements, as well as to perform a complete physical exam, it is also important to consult with an interprofessional team, including a dermatologist and pathologist. As other conditions must be ruled out with laboratory work prior to diagnosis, nurses are also vital to the interprofessional team, as they will collect blood specimens and assist with the education of the patient and family.</p>
      </sec>
      <sec id="article-17814.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17814&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17814">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/argyria/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17814">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17814/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17814">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17814.s16">
        <fig id="article-17814.image.f1" position="float" orientation="portrait">
          <caption>
            <p>A 92-year-old asymptomatic white man. Generalized argyria: For many years, this man had used nose drops containing silver. His skin biopsy showed silver deposits in the dermis, confirming the diagnosis of argyria. Although its pigmentary changes are permanent, argyria has no known effect on health. Courtesy of Herbert L. Fred, MD and Hendrik A. van Dijk (CC BY 2.0 https://creativecommons.org/licenses/by/2.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Argyria_2b" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17814.s17">
        <fig id="article-17814.image.f2" position="float" orientation="portrait">
          <caption>
            <p>A 92-year-old asymptomatic white man. Generalized argyria: For many years, this man had used nose drops containing silver. His skin biopsy showed silver deposits in the dermis, confirming the diagnosis of argyria. Although its pigmentary changes are permanent, argyria has no known effect on health. Courtesy of Herbert L. Fred, MD and Hendrik A. van Dijk (CC BY 2.0 https://creativecommons.org/licenses/by/2.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Argyria_2a" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17814.s18">
        <title>References</title>
        <ref id="article-17814.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dudeja</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dudeja</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Janakiraman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Babu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ocular argyrosis: A case with silver deposits in cornea and lens.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-268</page-range>
            <pub-id pub-id-type="pmid">30672485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sim</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Blaskovich</surname>
                <given-names>MAT</given-names>
              </name>
              <name>
                <surname>Ziora</surname>
                <given-names>ZM</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007&#x0207b;2017).</article-title>
            <source>Antibiotics (Basel)</source>
            <year>2018</year>
            <month>Oct</month>
            <day>26</day>
            <volume>7</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30373130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beutler</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Localized cutaneous argyria: Report of two patients and literature review.</article-title>
            <source>Dermatol Online J</source>
            <year>2016</year>
            <month>Nov</month>
            <day>15</day>
            <volume>22</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">28329568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lencastre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jo&#x000e3;o</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Argyria -- case report.</article-title>
            <source>An Bras Dermatol</source>
            <year>2013</year>
            <season>May-Jun</season>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>413</fpage>
            <page-range>413-6</page-range>
            <pub-id pub-id-type="pmid">23793191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drake</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Hazelwood</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Exposure-related health effects of silver and silver compounds: a review.</article-title>
            <source>Ann Occup Hyg</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>7</issue>
            <fpage>575</fpage>
            <page-range>575-85</page-range>
            <pub-id pub-id-type="pmid">15964881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fung</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Silver products for medical indications: risk-benefit assessment.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1996</year>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <page-range>119-26</page-range>
            <pub-id pub-id-type="pmid">8632503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Molina-Hernandez</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Diaz-Gonzalez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Saeb-Lima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dominguez-Cherit</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Argyria after Silver Nitrate Intake: Case Report and Brief Review of Literature.</article-title>
            <source>Indian J Dermatol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>520</fpage>
            <pub-id pub-id-type="pmid">26538722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mota</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dinis-Oliveira</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Forensic Aspects of the Different Subtypes of Argyria.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>May</month>
            <day>13</day>
            <volume>10</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34068024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cinotti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Labeille</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Douchet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cambazard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perrot</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy, reflectance confocal microscopy, and high-definition optical coherence tomography in the diagnosis of generalized argyria.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>76</volume>
            <issue>2S1</issue>
            <fpage>S66</fpage>
            <page-range>S66-S68</page-range>
            <pub-id pub-id-type="pmid">28087036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandez-Flores</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cassarino</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Mucocutaneous Hyperpigmentation in a Patient With a History of Both Minocycline and Silver Ingestion.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>916</fpage>
            <page-range>916-919</page-range>
            <pub-id pub-id-type="pmid">28475520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greene</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Argyria.</article-title>
            <source>Am Fam Physician</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>151</fpage>
            <page-range>151-4</page-range>
            <pub-id pub-id-type="pmid">3687674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferrara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Filosa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mariani</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Fasanella</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Occupational Argyria of the Nasal Mucosa.</article-title>
            <source>Head Neck Pathol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>252</fpage>
            <page-range>252-254</page-range>
            <pub-id pub-id-type="pmid">28779465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Argyria, an Unexpected Case of Skin Discoloration From Colloidal Silver Salt Ingestion.</article-title>
            <source>J Emerg Med</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>e39</fpage>
            <page-range>e39-e41</page-range>
            <pub-id pub-id-type="pmid">32591303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bracey</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Zipursky</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Juurlink</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Argyria caused by chronic ingestion of silver.</article-title>
            <source>CMAJ</source>
            <year>2018</year>
            <month>Feb</month>
            <day>05</day>
            <volume>190</volume>
            <issue>5</issue>
            <fpage>E139</fpage>
            <pub-id pub-id-type="pmid">29431112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of argyria using a low-fluence Q-switched 1064-nm Nd:YAG laser.</article-title>
            <source>Int J Dermatol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>751</fpage>
            <page-range>751-3</page-range>
            <pub-id pub-id-type="pmid">21595676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krase</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gottesman</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of Argyria Post Q-Switched Laser Treatment.</article-title>
            <source>Dermatol Surg</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>10</issue>
            <fpage>1308</fpage>
            <page-range>1308-1311</page-range>
            <pub-id pub-id-type="pmid">28296792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bray</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Falto-Aizpurua</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Yazdani Abyaneh</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Nouri</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>1064&#x000a0;nm Q-switched Nd:YAG laser for the treatment of Argyria: a systematic review.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>29</volume>
            <issue>11</issue>
            <fpage>2100</fpage>
            <page-range>2100-3</page-range>
            <pub-id pub-id-type="pmid">25845405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17814.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lazova</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Scar-localized argyria secondary to silver sulfadiazine cream.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>730</fpage>
            <page-range>730-2</page-range>
            <pub-id pub-id-type="pmid">14512929</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
